Resources for Professionals
Nolan Family Center for Cardiovascular Health
Cardiovascular Prevention Research Fellowship
Training in cardiovascular prevention is suboptimal. With our large population of prevention patients and excellent research opportunities, MHIF offers a high-quality, one-year fellowship training program in cardiovascular prevention for physicians. Find more information.
Cardiovascular Prevention Symposium
Each year, the Minneapolis Heart Institute® Cardiovascular Prevention Program sponsors a symposium on cardiovascular disease prevention for health professionals.
This conference educates physicians, advanced care providers and support staff on current guidelines and opinion on the identification and treatment of cardiovascular disease.
Stay tuned for details for our spring 2025 symposium.
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Dr. Michael Miedema, director of the Nolan Family Center for Cardiovascular Health at Minneapolis Heart Institute Foundation, was a member of the 2019 ACC/AHA Committee for the Primary Prevention of CVD Guidelines.
Prevention Publications and Lectures
Recent Prevention Publications
MHIF’s prevention team has authored hundreds of papers and presents frequently at national and international conferences. Read some of the latest publications from our team below.
April 2024: Prevalence of Lipoprotein(A) Testing and Utilization of Lipid Lowering Therapy in a Large Midwest Cohort
February 2024: Clinical characteristics and statin eligibility of patients under 50 with ST‐elevation myocardial infarction
December 2023: Coronary artery calcium and the risk of a cardiovascular events and mortality in younger adults: a meta-analysis
November 2023: Fourth Trimester: Assessing Women’s Health Equity and Long-Term Cardiovascular Outcomes in a Large Midwestern Health System in 2021
March 2023: Coronary Artery Calcium Dispersion and Cause-Specific Mortality
January 2023: Mortality impact of low CAC density predominantly occurs in early atherosclerosis: explainable ML in the CAC consortium
November 2022: Discordance Between Coronary Artery Calcium Area and Density Predicts Long-Term Atherosclerotic Cardiovascular Disease
September 2022: Coronary artery calcium to guide treatment in primary prevention—can we afford not to?
May 2022: Distribution of Coronary Artery Calcium by Age, Sex, and Race Among Patients 30-45 Years Old
March 2022: The Interplay of Race/Ethnicity and Obesity on the Incidence of Venous Thromboembolism
March 2022: Coronary Artery Calcium for Risk Assessment in Young Adults
May 2021: Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
Oct 2020: Machine Learning Adds to Clinical and CAC Assessments in Predicting 10-Year CHD and CVD Deaths
August 2020: A Most Pragmatic Panacea: Diet in the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
June 2020: Trends in prevalence of guideline-based use of lipid-lowering therapy in a large health system
February 2020: Trends in prevalence of guideline-based use of lipid-lowering therapy in a large health system
Jan 2020: Statin therapy for young adults: A long-term investment worth considering
Recent articles from The Coronary Artery Calcium (CAC) Consortium: The Coronary Artery Calcium Consortium is a multi-center observational cohort study from four clinical centers, including the Minneapolis Heart Institute Foundation, linked to long-term follow-up for cause-specific mortality. The CAC Consortium is large and highly generalizable data set that is uniquely positioned to expand the understanding of CAC as a predictor of mortality risk across the spectrum of disease states, allowing innovative modeling of the competing risks of cardiovascular and non-cardiovascular death.
Kevin Graham Prevention Lecture
|
This annual lecture honors the work of Dr. Kevin J. Graham and features international leaders in the field of cardiovascular prevention. A tireless and innovative thought leader in cardiology, Dr. Graham served as president of the Minneapolis Heart Institute® and the Cardiovascular Services Division of Abbott Northwestern Hospital from 2007 to 2012. He established and led the Preventive Cardiology practice and was Director of Outpatient Clinical Laboratory at the Minneapolis Heart. |
Image
|
Past lectures:
October 3, 2022 • Kevin Graham Prevention Lecture – From reading the genome for risk to rewriting it for cardiovascular health by Sekar Kathiresan, MD – CEO, Verve Therapeutics (Recording)
October 11, 2021 – Kevin Graham Prevention Lecture – The Evolution of the ABCs of Primary & Secondary Prevention of Cardiovascular Disease by Roger S. Blumenthal, MD, FACC, FAHA - Director, Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins Medical Institutions (Recording)
October 28, 2019 • Kevin Graham Prevention Lecture – Food is Medicine: Dietary and Policy Priorities for Cardiometabolic Health by Dariush Mozaffarian, MD, DrPH; Dean, Friedman School of Nutrition Science & Policy at Tufts University (Recording)
October 22, 2018 • Kevin Graham Prevention Lecture: Precision cardiovascular prevention: past, present, and future by Philip Greenland, MD, Harry W. Dingman Professor of Cardiology and Professor of Preventive Medicine, Northwestern University Feinberg School of Medicine (Recording)
Prevention Lectures from MHIF Grand Rounds
Watch recordings from past lectures on cardiovascular disease prevention and related topics.
December 7, 2022 • On the Pulse: What's the Big Deal About Cholesterol? by Dr. Elizabeth Tuohy (Recording)
May 21, 2021 • On the Pulse: Heart Health, Mental Health & Best Outcomes During COVID-19 by Courtney Jordan Baechler, MD, MS (Recording)
May 20, 2021 • On the Pulse: Fish Oil for the Prevention of Cardiovascular Disease by Michael Miedema, MD, MPH (Recording)
April 5, 2021 • A 2021 Cardiovascular Prevention Update by Courtney Jordan Baechler, MD, MS; Thomas Knickelbine, MD, FACC, FSCAI, FSCCT; Michael Miedema, MD, MPH; Elizabeth Tuohy, MD (Recording)
November 9, 2020 • AHA Preview: Predicted Versus Observed 10-year Cardiovascular Event Rates in a Rural Population-based Health Program: The Heart of New Ulm Project by Angela Phillips, DO (Recording)
October 26, 2020 • Equity in Cardiovascular Health Outcomes—Facts, Figures, and MHI Strategies to Close the Gap by Courtney Jordan Baechler, MD; Mosi Bennett, MD, PhD; Mario Gössl, MD, PhD (Recording)
January 27, 2020 • Does Mind Matter? by Kristin Hjartardottir, DNP, Psychiatry, Mental Health Nurse Practitioner, Abbott Northwestern Hospital (Recording)
November 4, 2019 • Cardiovascular Risk Reduction and the Role of New Antidiabetic Pharmacotherapies by Michael Miedema, MD, MPH (Recording)
September 23, 2019 • Renal Denervation Update 2019 by Yale Wang, MD, FACC, FSCAI (Recording)
January 21, 2019 • Global CVD Prevention: The Legs As a Window to the Heart by Jeremy R. Van’t Hof, MD, Cardiovascular Fellow, University of Minnesota (Recording)
December 10, 2018 • A 2018 cardiovascular prevention update by Michael D. Miedema, MD, MPH (Recording)
November 5, 2018 • 2018 AHA Scientific Sessions PREVIEW
Statin Eligibility and Prevalence of Statin Prescriptions According to the 2013 American College of Cardiology – American Heart Association Cholesterol Guidelines in a Large Multi-Center Healthcare System by Joseph C. Jensen, MD. (Recording)
October 29, 2018 • Prevention of heart disease & stroke in women by Gina Lundberg, MD, FACC, Associate Professor of Medicine, Emory University School of Medicine (Recording)
March 5, 2018 • ACC Scientific Sessions Preview (Recording)
PCSK9 Inhibitors in Patients With Familial Hypercholesterolemia and/or CVD: The Impact of a Systematic, Team-Based Approach to Prescription on Rates of Insurance Approval and Lipid Lowering by Thomas Knickelbine, MD
Sign Up For Our Newsletter
Stay up to date on MHIF news, events and the latest information on heart disease treatment and prevention.
